Day: May 3, 2024

We publish revised version of investors calendar.  Taking into consideration recent change in finance team of the Company, the Company plans to announce interim consolidated financial statements for 3 months as at May 22, 2024. 15 02 2024               Revenue and clients for January period 28 02 2024               Interim consolidated financial statements for 12 months of 2023 15 03 2024               Revenue and clients for February period 15 04 2024               Revenue and clients for March period Till 30 04 2024          Draft decisions of Annual General Meeting of Shareholders15 05 2024               Revenue and clients for April period 22 05 2024               Interim consolidated financial statements for 3 months of 2024 Till 31 05 2024          Decisions of Annual General Meeting of Shareholders 14 06 2024               Revenue...

New York, May 03, 2024 (GLOBE NEWSWIRE) — Blue World Acquisition Corporation (the “Company” or “Blue World”) (NASDAQ: BWAQ) today announced that, in order to extend the date by which the Company mush complete its initial business combination from May 2, 2024 to June 2, 2024, an aggregate of $60,000 (the “Extension Fee”) has been deposited into the Company’s trust account (the “Trust Account”). The payment for the Extension Fee was made by ZENIN INVESTMENTS LIMITED (“ZENIN”), one of the shareholders of Blue World Holdings Limited, the sponsor of the Company. The Company issued an unsecured promissory note to ZENIN for the deposit of the Extension Fee. About Blue World Acquisition Corporation Blue World Acquisition Corporation is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed...

UPM-Kymmene Corporation                Managers’ Transactions                        3 May 2024 at 12:30 EEST UPM-Kymmene Corporation: Managers’ Transactions (Kekki)  UPM-Kymmene Corporation has on 3 May 2024 received the following notification:   ____________________________________________Person subject to the notification requirementName: Mika KekkiPosition: Other senior managerIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64Notification type: INITIAL NOTIFICATION____________________________________________Transaction date: 2024-05-03Outside a trading venueInstrument type: SHAREISIN: FI0009005987Nature of transaction: REDEMPTION OF PLEDGE Transaction details(1): Volume: 1,000 Unit price: N/A Aggregated transactions (1): Volume: 1,000 Volume weighted average price: N/A____________________________________________ UPM, Media RelationsMon-Fri...

PARIS, FRANCE, May, 3rd, 2024 – Information on the total number of voting rights and shares in Tarkett’s share capital as of April, 30th, 2024 (Article L233-8-II of the French Commercial Code andArticle 223-16 of the General Regulation of the Autorité des marchés financiers)Date Total number of shares in the share capital Total number of voting rightsAs of April, 30th, 2024   65,550,281   Number of theoretical voting rights: 123 643 694  Number of exercisable voting rights: 123 625 135*  * After deduction of the treasury shares without voting rights. *** Investor Relations Contact investors@tarkett.com Media contacts Tarkett – communication@tarkett.com Brunswick – tarkett@brunswickgroup.com – Tel.: +33 (0) 1 53 96 83 83 About Tarkett With a 140-year history, Tarkett is a worldwide leader in innovative...

Oslo, Norway 3 May 2024 – The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 24 May 2024 at 10:00am (CEST). The notice and proposed resolutions to the annual general meeting are attached. The notice, including all appendices, will be made available at PCI Biotech’s corporate website www.pcibiotech.com. For further information, please contact:Ronny Skuggedal, CEO/CFO, E-mail: rs@pcibiotech.noOffice: +47 67 11 54 00 Mobile: +47 94 00 57 57 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentsPCI Biotech Innkalling GF 2024PCI Biotech Forslag til beslutninger GF 2024PCI Biotech Notice of AGM 2024PCI...

On 3 May 2024, the Annual General Meeting of the Shareholders of AS Ekspress Grupp was held in Tallinn, Narva road 13.   Out of 30 704 292 votes with voting rights, 25 445 992 votes were represented at the Meeting, i.e. 82.87% of the votes. The General Meeting of the Shareholders of AS Ekspress Grupp adopted the following resolutions. 1. The approval of the 2023 annual report of AS Ekspress Grupp To approve the 2023 annual report of AS Ekspress Grupp for the financial year from 1st of January 2023 to 31st of December 2023. 2. The approval of the proposal for distribution of profits To approve the Profit Distribution Proposal for 2023. To distribute a total EUR 3.35 million as follows:to pay dividends 6 (six) euro cents per share in the total amount of EUR 1.84 million; to increase statutory reserve by EUR 0.17 million; the remaining...

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 3 MAY 2024 AT 10:55 A.M. EET, OTHER INFORMATION DISCLOSED TO THE RULES OF THE EXCHANGEOma Savings Bank Plc: The Finnish Financial Supervisory Authority (FIN-FSA) has made a preliminary investigation request to the police Oma Savings Bank Plc (OmaSp or the Company) has been informed that the Finnish Financial Supervisory Authority (FIN-FSA) has made a preliminary investigation request to the police for securities market offences related to the Company. At the same time, the Finnish Financial Supervisory Authority (FIN-FSA) has said that it will investigate the need to impose administrative sanctions on the Company. In addition, the Finnish Financial Supervisory Authority states in its announcement that the Company’s financial situation is stable, and it has good liquidity and capital...